147 results
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
30 Nov 23
Condensed Consolidated Interim Financial Statements
1:05pm
course of business for which the ultimate tax determination is uncertain. The Company recognizes liabilities and contingencies for anticipated tax audit … issues based on the Company's current understanding of the tax law. For matters where it is probable that an adjustment will be made, the Company
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
30 Nov 23
Condensed Consolidated Interim Financial Statements
1:05pm
the ordinary course of business for which the ultimate tax determination is uncertain. The Company recognizes liabilities and contingencies … for anticipated tax audit issues based on the Company's current understanding of the tax law. For matters where it is probable that an adjustment will be made
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
24 Oct 23
Condensed Consolidated Interim Financial Statements
11:10am
and calculations are undertaken during the ordinary course of business for which the ultimate tax determination is uncertain. The Company recognizes … liabilities and contingencies for anticipated tax audit issues based on the Company's current understanding of the tax law. For matters where
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
24 Oct 23
Condensed Consolidated Interim Financial Statements
11:10am
and calculations undertaken during the ordinary course of business for which the ultimate tax determination is uncertain. The Company recognizes liabilities … and contingencies for anticipated tax audit issues based on the Company's current understanding of the tax law. For matters where it is probable
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
30 Aug 23
Notice of Annual General and Special Meeting of Shareholders
5:15pm
plan, retirement income fund, education savings plan or other similar savings or investment plan registered under the Income Tax Act (Canada
6-K
EX-99.2
00t4kqt0rit6
30 Aug 23
Notice of Annual General and Special Meeting of Shareholders
5:15pm
6-K
EX-99.2
y519koet
30 May 23
Condensed Consolidated Interim Financial Statements
5:40pm
6-K
EX-99.1
lvt8vm
30 May 23
Condensed Consolidated Interim Financial Statements
5:40pm
6-K
EX-99.2
1wft 10a0mak7
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
6-K
EX-99.1
2p5jwmxz2n6 ya3u03j
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
20-F/A
bohpf
12 Sep 22
Annual report (foreign) (amended)
6:17pm
6-K
EX-99.2
jyc4at3xdeti2y1sd ip
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.1
1fne m2gq8sdpx
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.3
8n0i8uyatbtf1x29
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.4
s18p kkqd4
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.1
gx3lsk
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.2
4k9c9a p4bot2hs
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.1
4nnj2 j5y0s3sv9lll
18 Nov 21
Notice of Annual General and Special Meeting of Shareholders
10:36am